Results 151 to 160 of about 549,379 (280)

Neoadjuvant Chemotherapy With Chemoradiotherapy for Patients With Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma— Retrospective Review From a Tertiary Care Hospital

Asia-Pacific Journal of Clinical Oncology, EarlyView.
A single‐centre retrospectively analyzed 37 BRPC/LAPC patients receiving neoadjuvant chemotherapy ± chemoradiotherapy. Surgical resection was feasible in 62% of patients, with 38% of patients achieving R0 resections. The median overall survival was 21 months, and disease‐free survival was 12.7 months.
Avtaj Nerwal, Desmond Yip, Sivakumar Gananadha, Amy Shorthouse, Belinda Lee, Ankit Jain   +5 more
wiley   +1 more source

A Resected Case of Pancoast Tumor with Concurrent Induction Chemoradiotherapy.

, 2000
宏 沖津, Hirokazu Takechi, 山井 礼道, 田渕 寛, 佐尾山 信夫, 吉田 沖   +5 more
openalex   +2 more sources

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison [PDF]

, 2005
K-C Soo, E-H Tan, Joseph Wee, D. Lim, B-C Tai, M-L Khoo, Charissa Goh, S-S Leong, Terence Tan, Ka-wing Fong, Ping Lü, A. See, David Machin   +12 more
openalex   +1 more source

Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective study

Translational Oncology
The efficacy of immunotherapy plus neoadjuvant chemotherapy and concurrent chemoradiotherapy (CCRT) for locally advanced nasopharyngeal carcinoma (LA-NPC) has not been reported. This study retrospectively compared the efficacy of tislelizumab plus neoadjuvant chemotherapy and CCRT with neoadjuvant chemotherapy followed by CCRT.Ninety patients with ...
Jiaqi He, Guoqing Luo, Shen Liu, Lingli Chen, Zihong Chen, Bing Zhang, Jiong Lin, Wenyi Qin, Haiwen Li, Haideng Zhou, Ying Yu, Dechao Zhan, Donghong Yang, Haiqing Luo   +13 more
openaire   +3 more sources

Individualized T3‐4N+ Rectal Cancer Treatment Strategies: Exploring the Efficacy of Preoperative Synchronized Lateral Lymph Node Simultaneous Integrated Boost Radiation Therapy

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Anatomical Diagram: It shows a cross‐section of the pelvic area highlighting the rectum and lateral lymph nodes, which are the focal points of the treatment strategy discussed in the paper. Flowchart: It outlines the treatment process from preoperative synchronized radiation therapy to the subsequent surgical procedures, illustrating the sequence of ...
Xinjue Shi, Siyao Zhong, Xianbin Zheng, Xianxiu Nan, Xuan Liu, Qiteng Liu, Jing Yuan, Yuyan Gao   +7 more
wiley   +1 more source

Concurrent Chemoradiotherapy for Locally Unresectable Head and Neck Cancer.

, 2000
Naoyuki Kohno, Satoshi Kitahara, Etuyo Tamura, Tetuya Tanabe, Manabu Nakanoboh, Yasuo Itoh, Yasuhiro Murata, Taichi Furukawa   +7 more
openalex   +2 more sources

Total Neoadjuvant Therapy Versus Conventional Neoadjuvant Therapy for Rectal Cancer: Cost Analysis in a Public Healthcare System

ANZ Journal of Surgery, EarlyView.
Costs of neoadjuvant therapy. ABSTRACT Purpose Total neoadjuvant therapy (TNT) has become the standard of care in locally advanced rectal cancer, but its economic impact is unclear. This study compares the cost of TNT with conventional neoadjuvant therapy (CNT), consisting of either short‐course radiotherapy or long‐course chemoradiotherapy, within a ...
Ishraq Murshed, Sergei Bedrikovetski, Ishmam Murshed, Zachary Bunjo, Tracy Fitzsimmons, Michelle Thomas, Tarik Sammour   +6 more
wiley   +1 more source

Multiagent Concurrent Chemoradiotherapy for Locoregionally Advanced Squamous Cell Head and Neck Cancer: Mature Results From a Single Institution [PDF]

, 2006
David J. Adelstein, Jerrold P. Saxton, Lisa Rybicki, Ramon M. Esclamado, Benjamin G. Wood, Marshall Strome, Pierre Lavertu, Robert R. Lorenz, M. A. Carroll   +8 more
openalex   +1 more source

Trends and Predictors of Total Neoadjuvant Therapy in Rectal Cancer: A Bi‐National Registry Study Across Australia and New Zealand

ANZ Journal of Surgery, EarlyView.
Neoadjuvant therapy type for LARC from 2018 to 2023. ABSTRACT Background Total Neoadjuvant Therapy (TNT) has significantly improved outcomes in locally advanced rectal cancer. Despite rising use and inclusion in international guidelines, adoption patterns in Australia and New Zealand (ANZ) remain unclear.
Ishraq Murshed, Sergei Bedrikovetski, Zachary Bunjo, Hidde M. Kroon, Michelle Thomas, Tarik Sammour   +5 more
wiley   +1 more source

Treatment of Stage IV(A–B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: Impact of chemotherapy schemes [PDF]

, 2006
T.K. Yau, Anne W.M. Lee, Dominique H.M. Wong, E. Pang, Wai Tong Ng, Rebecca M.W. Yeung, Inda Soong   +6 more
openalex   +1 more source